Form 4: Intuitive Surgical CFO Jamie Samath Executes Stock Options and Sells Shares Under 10b5-1 Plan

Intuitive Surgical's CFO, Jamie Samath, exercised stock options and sold shares on November 29, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Jamie Samath, the CFO of Intuitive Surgical, engaged in transactions involving the company's stock on November 29, 2024.
• These transactions included the exercise of non-qualified stock options and the subsequent sale of the acquired shares.
• The transactions were executed under a pre-arranged trading plan that complies with SEC Rule 10b5-1.
• A total of 188 shares were involved in the transactions, with 94 shares exercised at $208.90 and 94 shares at $290.33.
• The same 188 shares were then sold at a price of $539 per share.
• Following these transactions, Mr. Samath directly owns 8,757 shares of Intuitive Surgical stock.

Sentiment

Score: 5

Explanation: The document is a routine SEC filing related to stock transactions by an executive, and does not indicate any positive or negative sentiment.

Industry Context

This is a routine filing related to executive compensation and trading plans, common in publicly traded companies. It does not indicate any specific trend or event within the industry.

Comparison to Industry Standards

• Executive stock option exercises and sales are a common practice across publicly traded companies, particularly in the technology and healthcare sectors.
• The use of 10b5-1 trading plans is a standard method for executives to avoid accusations of insider trading.
• Companies like Medtronic, Stryker, and Johnson & Johnson also have similar executive compensation structures and trading practices.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are part of a pre-arranged trading plan.

Key Dates

Keywords

Intuitive Surgical, ISRG, stock options, SEC Form 4, insider trading, Jamie Samath, 10b5-1 plan, stock sale